TRACY LAMEY: Open Payments
NPI 1184608754 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 10 payments from 8 companies in 2025. Trend: 2023 $104 · 2024 $236 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $71 |
| Genentech USA, Inc. | 2 | $51 |
| Viatris Specialty LLC | 1 | $35 |
| Organon LLC | 1 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| CSL Behring | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Xolair, YUPELRI, VTAMA, NEFFY, CUVITRU, Hizentra, NUCALA.
Industry payments across AR — which companies pay providers there.
